The World Health Organization (WHO) on Tuesday announced an expanded partnership to improve access to COVID-19 technology, knowledge and clinical data, stressing the fight against the vir ...
Dallas: An analysis of electronic medical records for more than 45,000 people found that COVID-19 infection was significantly associated with the development of high blood pressure, accor ...
Scientists are tracking a highly mutated variant of the virus which causes COVID-19 to understand the extent it can spread or the manner in which it can react against human immunity.
The World Health Organization (WHO) is currently tracking several COVID-19 "variants of interest", including EG.5 which is on the rise in several countries, Director-General Ted ...
While no longer a global emergency, COVID-19’s lasting effects alongside such other threats as mpox and seasonal heat waves may challenge Europe through the summer months, the head ...
A new study published in The Lancet Infectious Diseases this week has found that metformin, a drug commonly used to treat diabetes, reduces the risk of long COVID.
Patients who had heart attacks during the first COVID-19 lockdown in the UK and Spain are predicted to live 1.5 and 2 years less, respectively, than their pre-COVID counterparts.
Researchers at The University of Queensland have discovered viruses such as SARS-CoV-2 can cause brain cells to fuse, initiating malfunctions that lead to chronic neurological symptoms.
Dhaka: Bangladesh registered two deaths due to COVID-19 for the first time in 66 days, as per data released by the government on Friday.
- WHO says nearly 7000 avoidable deaths reported in Europe due to COVID-19 pandemic
- More than one million lives were saved in Europe due to COVID-19 vaccines, says WHO
- Study shows vaccine lowers risk of COVID-19 in children
- Indian pharmaceutical firm's COVID vaccine Corbevax gets WHO's emergency use listing
- WHO alerts COVID-19 risk still remains high

